Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial

JAMA Internal Medicine
Jean S KutnerAmy P Abernethy

Abstract

For patients with limited prognosis, some medication risks may outweigh the benefits, particularly when benefits take years to accrue; statins are one example. Data are lacking regarding the risks and benefits of discontinuing statin therapy for patients with limited life expectancy. To evaluate the safety, clinical, and cost impact of discontinuing statin medications for patients in the palliative care setting. This was a multicenter, parallel-group, unblinded, pragmatic clinical trial. Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease. Participants were randomized to either discontinue or continue statin therapy and were monitored monthly for up to 1 year. The study was conducted from June 3, 2011, to May 2, 2013. All analyses were performed using an intent-to-treat approach. Statin therapy was withdrawn from eligible patients who were randomized to the discontinuation group. Patients in the continuation group continued to receive statins. Outcomes included death within 60 days (primary outcome), surv...Continue Reading

References

Dec 28, 1999·JAMA : the Journal of the American Medical Association·J C LaRosaS Vupputuri
Jun 3, 2004·Annals of Internal Medicine·Frederick A SpencerUNKNOWN GRACE Investigators
Oct 16, 2004·BMJ : British Medical Journal·James StevensonDavid C Currow
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Sep 1, 2005·Journal of Palliative Medicine·Annette M VollrathJames Hallenbeck
Mar 29, 2006·Archives of Internal Medicine·Holly M HolmesGreg A Sachs
Apr 4, 2006·The American Journal of Cardiology·Paul D ThompsonUNKNOWN National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel
Nov 30, 2006·Archives of Internal Medicine·Paaladinesh ThavendiranathanNiteesh K Choudhry
Jun 15, 2007·Lancet·Jane Armitage
Nov 7, 2007·The New England Journal of Medicine·John KjekshusUNKNOWN CORONA Group
Jul 1, 2008·Journal of Palliative Medicine·Maria J SilveiraMatthew P Shevrin
Jun 29, 2010·Current Opinion in Lipidology·Guru M Krishnan, Paul D Thompson
Dec 22, 2010·The Annals of Thoracic Surgery·Ko Bando
Nov 15, 2011·Current Pharmaceutical Design·Yessica-Haydee Gomez SandovalStella S Daskalopoulou
Jun 13, 2012·Archives of Internal Medicine·Beatrice A GolombHalbert L White
Nov 28, 2012·Circulation·Beth A ParkerPaul D Thompson
Jan 4, 2013·The New England Journal of Medicine·Emily Oshima Lee, Ezekiel J Emanuel
Jul 24, 2013·JAMA Internal Medicine·Ishak MansiEric M Mortensen
Aug 15, 2013·JAMA : the Journal of the American Medical Association·Paul M Ridker, Peter W F Wilson
Aug 28, 2013·Journal of General Internal Medicine·Richard M Hoffman, Mary McNaughton-Collins
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Mar 22, 2014·The New England Journal of Medicine·Michael J PencinaEric D Peterson
Mar 26, 2014·Palliative Medicine·Matteo MoroniUNKNOWN on behalf of the SUQ-P group

❮ Previous
Next ❯

Citations

Dec 8, 2015·Expert Review of Anti-infective Therapy·Jon P FurunoErik K Fromme
Feb 13, 2016·Journal of Gerontological Nursing·Nicole J Brandt
Jan 27, 2016·Wiener medizinische Wochenschrift·Peter Dovjak
Jun 9, 2016·Current Cardiovascular Risk Reports·Shannon M Dunlay, Alanna M Chamberlain
Dec 25, 2015·The New England Journal of Medicine·Craig D Blinderman, J Andrew Billings
Jun 17, 2015·International Journal of Clinical Pharmacy·Adam Todd, Holly M Holmes
Jun 14, 2015·European Journal of Clinical Pharmacology·Barbara Caecilia WimmerJ Simon Bell
Nov 4, 2015·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Marco ProiettiGregory Y H Lip
Jul 6, 2016·The Canadian Journal of Cardiology·Dae Hyun Kim, Michael W Rich
Jul 28, 2016·Maturitas·Amy Theresa PageChristopher Etherton-Beer
Jul 8, 2015·The Lancet Oncology·Thomas W LeBlancAmy P Abernethy
Aug 25, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Manon C Stam-SlobStella Trompet
Sep 10, 2016·Age and Ageing·Heidi TaipaleSirpa Hartikainen
Sep 25, 2016·Journal of Pain and Symptom Management·Michael J HochmanThomas W LeBlanc
Oct 16, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Mario IannacconeSasko Kedev
Dec 18, 2016·Expert Opinion on Drug Safety·Jorge Enrique Machado-AlbaLaura Chica
Sep 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristen Marie SanfilippoKenneth R Carson
Mar 16, 2017·Gaceta sanitaria·Miguel Ángel Royo-BordonadaUNKNOWN en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC)
Apr 25, 2017·Geriatrics & Gerontology International·Hsien-Yeh ChuangFei-Yuan Hsiao
Apr 28, 2017·Journal of Palliative Medicine·Christine L RitchieJean S Kutner
May 19, 2017·Journal of Palliative Medicine·Jennifer TjiaJon P Furuno
Jun 1, 2017·Journal of Palliative Medicine·Nrupen A BhavsarDonald H Taylor
Jun 9, 2017·Journal of Oncology Practice·Alison WiesenthalDeborah Korenstein
Jan 21, 2017·Heart Failure Reviews·Jeffrey L Spiess
Jan 4, 2017·Journal of Pain and Symptom Management·David C CurrowRussell K Portenoy
Feb 9, 2017·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·M Á Royo-BordonadaUNKNOWN en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC)
Apr 4, 2017·Journal of the American Geriatrics Society·Jeremy N MatlowPaula A Rochon
Dec 27, 2016·Hipertensión y riesgo vascular·M Á Royo-BordonadaUNKNOWN en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC)
Apr 17, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Timo E StrandbergHannu Kautiainen
Jan 24, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Richard Ofori-AsensoSophia Zoungas
Sep 12, 2017·Journal of the American Geriatrics Society·Ariela R OrkabyJane A Driver
Dec 1, 2017·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Kristie WeirJesse Jansen
Jul 28, 2015·The American Journal of Hospice & Palliative Care·Adam G GoldenDenise Gammonley
Sep 10, 2016·The Cochrane Database of Systematic Reviews·Bernadette McGuinnessPeter Passmore
Mar 7, 2018·Journal of the American Geriatrics Society·Patrick M ZuegerTodd A Lee
Sep 28, 2017·Journal of Palliative Medicine·Jimmy J ArevaloRoberto S G M Perez
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Jul 12, 2018·Circulation. Cardiovascular Quality and Outcomes·Alexis A KrummeJoshua J Gagne
Sep 20, 2018·Palliative Medicine·Kristel PaqueThierry Christiaens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.